Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Featured

Featured

Featured posts

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

ME Staff - March 17, 2024
DelMar

Here Are Two Phase II Trials To Watch: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and argenx SE – American Depositary Shares (NASDAQ:ARGX)

FDA

Deconstructing the Lipocine Inc (NASDAQ:LPCN) Complete Response Letter

Voyager

Biotech Movers: Bristol-Myers Squibb Company (NYSE:BMY) and Merck (NYSE:MRK)

stocks

The Three Most Important Questions For TESARO Inc (NASDAQ:TSRO) Shareholders Right Now

Here’s Why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Is Gaining Strength Today

- July 11, 2017 0

FDA’s Sanofi SA (ADR) (NYSE:SNY) Delay Highlights Some Red Flags With...

- August 22, 2016 1
Diabetes

For Diabetes Patients, Management Solutions Are As Critical As Medications

ME Staff - May 10, 2018 0

Here’s What Opko Gets For Its $60 Million Transition Fee –...

- July 5, 2016 0

Midweek biotech Movers: Neuralstem, Inc. (NASDAQ:CUR) and Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX)

- July 26, 2017 0
Market Morning

Market Morning: Epstein Dead, Mattel Gets Threatened, Greenspan Worried, Walmart Inflation

ME Staff - August 12, 2019 0

Cannabis Stock News Daily Roundup July 12

ME Staff - July 12, 2019 0

Here’s What’s Important About The July Kala Pharmaceuticals Inc (NASDAQ:KALA) IPO

- August 11, 2017 0

Here’s What’s Moving Immunomedics, Inc. (NASDAQ:IMMU) and Ocera Therapeutics Inc (NASDAQ:OCRX)

- March 10, 2017 0
Market Morning

Market Morning: Uber Grounded in NYC, MoviePass Sees The Light, Lira...

ME Staff - August 9, 2018 0
123...148Page 1 of 148

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 2, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 13, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 6, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019